C型肝炎治療的新選擇―― Sovaldi® …

HEPATITIS C DIRECT ACTING ANTIVIRALS (DAA)

Division: Pharmacy Policy Subject: Prior Authorization Criteria Original Development Date: Original Effective Date: Revision Date: February 17, 2017

Procedures, programs and drugs you must precertify

Procedures, programs and drugs you must precertify Participating provider precertification list Effective July 1, 2018 . Applies to. 1,2,3,4,9: Aetna

  Programs, Drug, Aetna, Procedures, Programs and drugs you

Pharmacy Medical Policy Hepatitis C Medication …

5 OR genotype 1a or 3 infection AND have previously been treated with an HCV regimen containing sofosbuvir without an NS5A inhibitor.

  Policy, Medical, Medication, Hepatitis, Sofosbuvir, Medical policy hepatitis c medication

(sofosbuvir/velpatasvir)tablets 400mg/100mg …

EPCLUSA(sofosbuvir/velpatasvir) tablets Product Monograph Page 2of 63 TABLE OF CONTENTS PART I: HEALTH PROFESSIONAL INFORMATION.....3

  Tablets, Sofosbuvir, 100mg, 400mg, Sofosbuvir velpatasvir, Velpatasvir, Tablets 400mg 100mg

HIGHLIGHTS OF PRESCRIBING INFORMATION 4, 5, …

1 HIGHLIGHTS OF PRESCRIBING INFORMATION 4, 5, or 6 These highlights do not include all the information needed to use HARVONI ® safely and effectively. See full prescribing information

  Information, Prescribing, Prescribing information